Suppr超能文献

慢性肝衰竭急性发作的患者表现出“脓毒症样”免疫麻痹。

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

作者信息

Wasmuth Hermann E, Kunz Dagmar, Yagmur Eray, Timmer-Stranghöner Annette, Vidacek Daniel, Siewert Elmar, Bach Jens, Geier Andreas, Purucker Edmund A, Gressner Axel M, Matern Siegfried, Lammert Frank

机构信息

Department of Medicine III, University Hospital Aachen (UKA), Aachen University (RWTH), Pauwelsstrasse 30, D-52074 Aachen, Germany.

出版信息

J Hepatol. 2005 Feb;42(2):195-201. doi: 10.1016/j.jhep.2004.10.019.

Abstract

BACKGROUND/AIMS: Cellular immune depression is linked to high mortality in sepsis, but has yet to be systematically analysed in liver cirrhosis. The aim of the present study was to directly compare functional immune parameters in patients with acute on chronic liver failure (ACLF), severe sepsis, and non-decompensated cirrhosis.

METHODS

Patients with ACLF (n=27) were investigated at admission to a medical ICU. Patients with stable liver cirrhosis (n=24) and severe sepsis (n=31) served as control groups. In all subjects, serum levels of IL-6 and IL-10, ex vivo production of TNF-alpha in a whole blood assay, and monocyte surface HLA-DR expression were determined.

RESULTS

In patients with ACLF or sepsis, ex vivo TNF-alpha production and HLA-DR expression were severely decreased compared to subjects with stable cirrhosis (both P<0.001). Contrary, IL-6 levels were highest in septic patients, followed by subjects with ACLF and cirrhotic patients (both P<0.05). Immune dysfunction in ACLF was independent of aetiology of liver cirrhosis and associated with high mortality.

CONCLUSIONS

Patients with ACLF and severe sepsis show a similar degree of cellular immune depression. The reduced cellular immune function in subjects with ACLF might contribute to the increased infectious morbidity of these patients and provide a rational basis for prevention strategies.

摘要

背景/目的:细胞免疫抑制与脓毒症的高死亡率相关,但在肝硬化中尚未进行系统分析。本研究的目的是直接比较急性慢性肝衰竭(ACLF)、严重脓毒症和非失代偿性肝硬化患者的功能性免疫参数。

方法

对入住内科重症监护病房的ACLF患者(n = 27)进行调查。稳定肝硬化患者(n = 24)和严重脓毒症患者(n = 31)作为对照组。测定所有受试者的血清白细胞介素-6(IL-6)和白细胞介素-10水平、全血检测中肿瘤坏死因子-α(TNF-α)的体外产生以及单核细胞表面人类白细胞抗原-DR(HLA-DR)表达。

结果

与稳定肝硬化患者相比,ACLF或脓毒症患者的体外TNF-α产生和HLA-DR表达严重降低(均P < 0.001)。相反,脓毒症患者的IL-6水平最高,其次是ACLF患者和肝硬化患者(均P < 0.05)。ACLF中的免疫功能障碍与肝硬化病因无关,且与高死亡率相关。

结论

ACLF和严重脓毒症患者表现出相似程度的细胞免疫抑制。ACLF患者细胞免疫功能降低可能导致这些患者感染发病率增加,并为预防策略提供合理依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验